Next generation risk assessment (NGRA): Bridging in vitro points-of-departure to human safety assessment using physiologically-based kinetic (PBK) modelling ? A case study of doxorubicin with dose metrics considerations
Li, HQ; Yuan, HT; Middleton, A; Li, J; Nicol, B; Carmichael, P; Guo, JB; Peng, SQ; Zhang, Q
Peng, SQ (corresponding author), Acad Mil Med Sci, Inst Dis Control & Prevent, Evaluat & Res Ctr Toxicol, Beijing 100071, Peoples R China.; Zhang, Q (corresponding author), Emory Univ, Dept Environm Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.
TOXICOLOGY IN VITRO, 2021; 74 ():